Literature DB >> 9042621

Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography.

A U Wells1, M B Rubens, R M du Bois, D M Hansell.   

Abstract

Thin-section computed tomography (CT) provides a reproducible method of quantifying global disease extent and can also discriminate between fibrotic disease, with predominance of reticular abnormalities, and reversible inflammatory cell infiltration, shown as ground-glass attenuation. The aim of this study was to determine whether functional impairment varied according to the presence of ground-glass attenuation on CT, independently of extent of disease on CT, demographic factors, smoking history, therapeutic status, and the type of fibrosing alveolitis (lone cryptogenic fibrosing alveolitis (CFA) versus fibrosing alveolitis associated with systemic sclerosis (FASSc)). Patients with concurrent emphysema on CT (n = 16) and FASSc patients with end-stage pulmonary hypertension (n = 5) were excluded. One hundred and eleven patients were studied (CFA, n = 54; FASSc, n = 57). The severity of functional impairment did not vary independently with the presence of predominant ground-glass attenuation, mixed appearance and predominant reticulation on CT. In 34 treated patients undergoing serial CT scanning, the severity of functional impairment did not differ independently between patients with and without regression of ground-glass attenuation at follow-up. We conclude that the severity of functional impairment does not discriminate between inflammatory and fibrotic disease in fibrosing alveolitis, as judged by initial and serial computed tomographic scanning, after adjustment for the morphological extent of disease on computed tomography.

Entities:  

Mesh:

Year:  1997        PMID: 9042621     DOI: 10.1183/09031936.97.10020280

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

Review 1.  Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis.

Authors:  A Wells
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 2.  Ultrasound as a potential tool for the assessment of interstitial lung disease in rheumatic patients. Where are we now?

Authors:  Marwin Gutierrez; Marika Tardella; Luis Rodriguez; Jaime Mendoza; Denise Clavijo-Cornejo; Antonio García; Chiara Bertolazzi
Journal:  Radiol Med       Date:  2019-07-02       Impact factor: 3.469

Review 3.  Ultrasound in the interstitial pulmonary fibrosis. Can it facilitate a best routine assessment in rheumatic disorders?

Authors:  Marwin Gutierrez; Luis Enrique Gomez-Quiroz; Denise Clavijo-Cornejo; Carlos A Lozada; Ana C Lozada-Navarro; Roxana U Miranda Labra; Javier Fernandez-Torres; Guadalupe Sanchez-Bringas; Fausto Salaffi; Chiara Bertolazzi; Carlos Pineda
Journal:  Clin Rheumatol       Date:  2016-06-21       Impact factor: 2.980

4.  Utility of a simplified ultrasound assessment to assess interstitial pulmonary fibrosis in connective tissue disorders--preliminary results.

Authors:  Marwin Gutierrez; Fausto Salaffi; Marina Carotti; Marika Tardella; Carlos Pineda; Chiara Bertolazzi; Elisabetta Bichisecchi; Emilio Filippucci; Walter Grassi
Journal:  Arthritis Res Ther       Date:  2011-08-18       Impact factor: 5.156

5.  Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function.

Authors:  Tadeusz M Zielonka; U Demkow; E Radzikowska; B Bialas; M Filewska; K Zycinska; M H Obrowski; J Kowalski; K A Wardyn; E Skopinska-Rozewska
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

6.  Sarcoidosis: assessment of disease severity using HRCT.

Authors:  Marjolein Drent; Jolanda De Vries; Merinke Lenters; Rob J S Lamers; Snjezana Rothkranz-Kos; Emiel F M Wouters; Marja P van Dieijen-Visser; Johny A Verschakelen
Journal:  Eur Radiol       Date:  2003-06-17       Impact factor: 5.315

7.  Diagnostic performances of high resolution trans-thoracic lung ultrasonography in pulmonary alveoli-interstitial involvement of rheumatoid lung disease.

Authors:  Miramir Aghdashi; Behdad Broofeh; Afshin Mohammadi
Journal:  Int J Clin Exp Med       Date:  2013-08-01

8.  Angiogenic activity of sera from interstitial lung disease patients in relation to clinical and radiological changes.

Authors:  T M Zielonka; U Demkow; K Zycinska; M Filewska; B Bialas; J Kus; E Radzikowska; P Remiszewski; J Szopinski; A Soszka; K A Wardyn; E Skopinska-Rozewska
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

9.  Clearance of technetium-99m-DTPA and HRCT findings in the evaluation of patients with Idiopathic Pulmonary Fibrosis.

Authors:  Katerina M Antoniou; Katerina Malagari; Nikolaos Tzanakis; Kostas Perisinakis; Emmanouil K Symvoulakis; Nikolaos Karkavitsas; Nikolaos M Siafakas; Demosthenes Bouros
Journal:  BMC Pulm Med       Date:  2006-02-16       Impact factor: 3.317

Review 10.  High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?

Authors:  Barbara Ruaro; Elisa Baratella; Paola Confalonieri; Marco Confalonieri; Fabio Giuseppe Vassallo; Barbara Wade; Pietro Geri; Riccardo Pozzan; Gaetano Caforio; Cristina Marrocchio; Maria Assunta Cova; Francesco Salton
Journal:  Diagnostics (Basel)       Date:  2021-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.